ERBB2 and neoplasm: Besides the expected very favorable accumulation in the HER2-positive tumor that could be observed, which is mediated by the highly specific antibody, also a high in vivo bone accumulation of 13.2% ± 2.4% could be detected as early as 24 h p.i..